|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: FLO-PRED
Summary for Tradename: FLO-PRED
|
| Pharmacology for Tradename: FLO-PRED
| ||||||||||||
Clinical Trials for: FLO-PREDBiomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) Status: Recruiting Condition: Systemic Lupus Erythematosus Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS) Status: Suspended Condition: Acute Exacerbation of Remitting Relapsing Multiple Sclerosis; Clinically Isolated Syndrome Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone Status: Terminated Condition: Multiple Sclerosis A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte Status: Completed Condition: Eye Infections; Postoperative Complications A Comparison of Three Different Formulations of Prednisolone Acetate 1% Status: Completed Condition: Glaucoma; Cataract The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia Status: Completed Condition: Eosinophilic Pneumonia; Chronic Disease Biomarkers of Prednisolone Treatment (Study 294001)(COMPLETED) Status: Completed Condition: Insulin Resistance; Hyperglycemia; Glucose Intolerance A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Status: Withdrawn Condition: Therapeutic Equivalency A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions Status: Withdrawn Condition: Therapeutic Equivalency A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions Status: Withdrawn Condition: Therapeutic Equivalency Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | FLO-PRED | prednisolone acetate | SUSPENSION; ORAL | 022067 | Jan 17, 2008 | DISCN | No | 5,881,926 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taro | FLO-PRED | prednisolone acetate | SUSPENSION; ORAL | 022067 | Jan 17, 2008 | DISCN | No | 6,071,523 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taro | FLO-PRED | prednisolone acetate | SUSPENSION; ORAL | 022067 | Jan 17, 2008 | DISCN | No | 6,102,254 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taro | FLO-PRED | prednisolone acetate | SUSPENSION; ORAL | 022067 | Jan 17, 2008 | DISCN | No | 6,399,079 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc
